The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Ionis Pharmaceuticals Inc shares valued at $600,000 were sold by KLEIN JOSEPH III on Jul 16 ’24. At $50.00 per share, KLEIN JOSEPH III sold 12,000 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Diaz Allene M. sold 1,637 shares, netting a total of over 81,019 in proceeds. Following the sale of shares at $49.49 each, the insider now holds 15,716 shares.
Before that, BERTHELSEN SPENCER R had sold 16,000 shares from its account. In a trade valued at $644,640, the Director traded Ionis Pharmaceuticals Inc shares for $40.29 each. Upon closing the transaction, the insider’s holdings decreased to 16,000 shares, worth approximately $7.28 million.
As published in a research note from Leerink Partners on July 24, 2024, Ionis Pharmaceuticals Inc [IONS] has been rated up from a Market perform to an Outperform and the price target has been revised to $62 from $53. As of June 14, 2024, Bernstein has increased its “an Underperform” rating to a “Mkt perform” for IONS. Earlier on April 10, 2024, Wolfe Research upgraded its rating. Their new recommendation was “an Outperform” for IONS stock which previously was a “a Peer perform”.
Analyzing IONS Stock Performance
During the last five days, there has been a drop of approximately -2.52%. Over the course of the year, Ionis Pharmaceuticals Inc shares have dropped approximately -2.23%. Shares of the company reached a 52-week high of $54.44 on 01/12/24 and a 52-week low of $35.95 on 05/31/24. A 50-day SMA is recorded $44.05, while a 200-day SMA reached $45.83. Nevertheless, trading volume fell to 1.07 million shares from 1.13 million shares the previous day.
Support And Resistance Levels for Ionis Pharmaceuticals Inc (IONS)
According to the 24-hour chart, there is a support level at 48.93, which, if violated, would cause prices to drop to 48.39. In the upper region, resistance lies at 50.45. The next price resistance is at 51.43. RSI (Relative Strength Index) is 57.64 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.32, which suggests the price will decrease in the coming days. Percent R is at 50.00%, indicating low price movement. Stochastics%K at holding indicates that the stock is to be held.
